POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON COMPLEMENT 3 GLOMERULOPATHY HISTOLOGIC INDEX OF DISEASE CHRONICITY

Autor: Bomback, A., Herlitz, L.C., Yue, H., Kedia, P.P., Schall, T.J., Bekker, P.
Zdroj: In Kidney International Reports February 2022 7(2) Supplement:S47-S48
Databáze: ScienceDirect